World Drug Manufacturing Summit 2011

The 2011 WDM programme will address the major issues affecting the pharmaceutical and biotech industries at the current time:

Change management – managing the impact of opex programmes, company restructuring and globalisation on people and processes
Cost reduction – understanding and reducing manufacturing costs through process economics, improved process design and operational excellence
Changing product portfolios – flexible and multi-product production facilities to meet the needs of portfolios based on more diverse products
Anti-counterfeiting & serialisation – implementing serialisation technologies in preparation for country-specific track & trace legislation
Technology developments - implementing the latest solutions to improve control and decision making in manufacturing - MES, QbD and PAT
Globalisation – the impact on manufacturing strategy and facility management